Related Experiment Video
Updated: Apr 28, 2026
Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
Published on: July 10, 2018
Resolving Endoplasmic Reticulum-Protein Misfolding Restores Corticosteroid Sensitivity in Experimental Models of
Prabuddha S Pathinayake1, Alexandra C Brown2, Nikhil T Awatade3
1Infection Research Program, Hunter Medical Research Institute and School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, New South Wales, Australia.
Background:
People with severe steroid-resistant asthma are refractory to treatment with the mainstay inhaled corticosteroids (ICS), emphasising the urgent need for alternative therapies. This study aimed to assess the effect of endoplasmic reticulum stress (ERS) on steroid responsiveness and to evaluate the efficacy of 4-phenylebuteric acid (4-PBA) as an add-on treatment to restore steroid responses in severe asthma.
Methods:
The relationship between ERS and steroid response was assessed by treating human airway epithelial cells (AEC) with chemical ERS inducers or TNF, IFN-γ, and IL-17, and assessing the effects of dexamethasone (Dex) and 4-PBA. The correlation between genes associated with ERS and GR-signalling was assessed in sputum cells from patients with severe asthma, and the effects of 4-PBA were assessed in two murine models of severe, steroid-resistant asthma.
Results:
Chemical ERS inducers significantly downregulated the expression of corticosteroid-responsive genes, HSD11B2 and FKBP5 and reduced GR nuclear translocation in basal AECs. Treatment with TNF, IFN-γ and IL-17 upregulated ERS and protein misfolded markers while reducing Dex-induced GR nuclear translocation. In sputum cells from patients with severe asthma, ERS genes negatively correlated with GR-signalling. In differentiated primary bronchial epithelial cells (pBECs), treatment with 4-PBA reversed TNF, IFN-γ and IL-17-induced steroid resistance by upregulating HSD11B2 and FKBP5 gene expression and downregulating inflammatory genes. 4-PBA together with Dex significantly reduced airway inflammation and/or AHR in experimental models of severe, steroid-resistant asthma.
Conclusion:
We provide evidence for ERS inducing steroid resistance that underpins severe asthma and demonstrate a therapeutic potential for restoring steroid sensitivity in severe asthma with 4-PBA.
Related Concept Videos
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:19Cushing Syndrome II: Pathophysiology
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...